The TCGA database also showed that the mRNA level of CBX3 was significantly correlated with the overall survival time of patients with pancreatic cancer [20], hepatocellular carcinoma [21], prostate cancer [16], and glioma [22, 23]. This evidence concerns the gene CBX3 and Familial prostate cancer.